Cipla Ltd.

BSE: 500087 | NSE: CIPLA
Large Cap | Pharmaceuticals & Drugs
1438.75
-2.95 (-0.20%)
< Home < Back

Cipla informs about press release

Date: 29-10-2018

Cipla informs about Press Release dated 29th October, 2018, for final approval of generic version of Aralez Pharmaceuticals, Inc.’s Toprol XL (Metoprolol Succinate) ER Tablets 50mg, 100mg, 200mg.

The above information is a part of company’s filings submitted to BSE.